Skip to main content
. 2015 Mar 16;6(11):9600–9611. doi: 10.18632/oncotarget.3292

Figure 2. Kaplan–Meier estimates of disease-free survival (DFS) and overall survival (OS) according to receptor conversions.

Figure 2

(a) DFS for hormone receptor (HR) conversion (log-rank test: P < 0.001), (b) DFS for human epidermal growth factor receptor 2 (HER2) conversion (log-rank test: P < 0.001), (c) OS for HR conversion (log-rank test: P < 0.001), (d) OS for HER2 conversion (log-rank test: P = 0.007).